How big is the Cancer Cachexia Market?

The Cancer Cachexia Market size is expected to reach USD 2.72 billion in 2024 and grow at a CAGR of 4.19% to reach USD 3.34 billion by 2029. Read More

What is the current Cancer Cachexia Market size?

In 2024, the Cancer Cachexia Market size is expected to reach USD 2.72 billion. Read More

Who are the key players in Cancer Cachexia Market?

Merck & Co. Inc., Aphios Corporation, Helsinn Group, Bristol-Myers Squibb Company and Pfizer are the major companies operating in the Cancer Cachexia Market. Read More

Which is the fastest growing region in Cancer Cachexia Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Cancer Cachexia Market?

In 2024, the North America accounts for the largest market share in Cancer Cachexia Market. Read More

What years does this Cancer Cachexia Market cover, and what was the market size in 2023?

In 2023, the Cancer Cachexia Market size was estimated at USD 2.61 billion. The report covers the Cancer Cachexia Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cancer Cachexia Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Cancer Cachexia Market Share

Statistics for the 2023 & 2024 Cancer Cachexia market share, created by Mordor Intelligence™ Industry Reports. Cancer Cachexia share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Cancer Cachexia Industry

The cancer cachexia market is consolidated in nature due to the presence of very few major companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. Key market players include Aeterna Zentaris, Aphios Corporation, Bristol-Myers Squibb Company, Pfizer Inc., Helsinn Group, Merck KGaA, Artelo Biosciences Inc., NGM Biopharmaceuticals, Aveo Oncology, Aavogen Inc., Green Cross Wellbeing Corporation, Cannabics Pharmaceuticals Inc., TCI Peptide Therapeutics, Fresenius Kabi, Tetra Bio-Pharma, and Actimed Therapeutics among others.